Almoosa Health Company (TADAWUL:4018)

Saudi Arabia · Delayed Price · Currency is SAR

111.60

-0.60 (-0.53%)

Oct 15, 2026, 3:17 PM AST

Almoosa Health Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,944	7,771	-	-	-	-
Market Cap Growth	-40.54%	-	-	-	-	-
Enterprise Value	6,320	8,384	-	-	-	-
Last Close Price	111.60	174.20	-	-	-	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	30.26	32.85	-	-	-	-
Forward PE	21.98	27.28	-	-	-	-
PS Ratio	3.30	5.49	-	-	-	-
PB Ratio	2.52	4.04	-	-	-	-
P/TBV Ratio	2.54	4.06	-	-	-	-
P/OCF Ratio	30.45	42.97	-	-	-	-
PEG Ratio	1.85	0.70	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.22	5.92	-	-	-	-
EV/EBITDA Ratio	20.49	27.49	-	-	-	-
EV/EBIT Ratio	30.84	38.17	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.74	0.45	2.31	1.86	1.23	0.86
Debt / EBITDA Ratio	4.68	2.77	5.48	6.46	7.07	5.39
Net Debt / Equity Ratio	0.70	0.41	2.25	1.83	1.20	0.76
Net Debt / EBITDA Ratio	4.65	2.59	5.47	6.58	7.40	5.11
Net Debt / FCF Ratio	-2.36	-2.78	-24.83	-3.51	-2.45	-3.77
Asset Turnover	0.43	0.48	0.50	0.47	0.48	0.50
Inventory Turnover	13.07	13.56	13.07	12.33	11.76	10.58
Quick Ratio	1.64	1.50	0.93	0.95	0.82	0.76
Current Ratio	1.90	1.72	1.11	1.12	0.99	0.95
Return on Equity (ROE)	8.44%	18.55%	7.70%	15.05%	8.19%	10.51%
Return on Assets (ROA)	3.62%	4.68%	4.69%	3.76%	2.06%	2.98%
Return on Invested Capital (ROIC)	6.19%	9.09%	7.99%	7.28%	4.11%	5.99%
Return on Capital Employed (ROCE)	5.90%	7.70%	9.20%	6.80%	3.90%	5.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	3.30%	3.04%	-	-	-	-
FCF Yield	-11.77%	-3.66%	-	-	-	-
Dividend Yield	1.25%	0.74%	-	-	-	-
Payout Ratio	35.25%	36.52%	28.38%	-	-	25.09%
Buyback Yield / Dilution	-12.17%	-26.15%	-	-	-34900.00%	-
Total Shareholder Return	-10.92%	-25.40%	-	-	-34900.00%	-